Article contributed by
Patience Jeffrey
RTI Marketing Specialist
We’re excited to announce that AJ Messina has joined RTI Health Solutions (RTI-HS), where he will play a key role in advancing Implementation Science within pharmaceutical research and development. AJ’s expertise will help bridge the gap between drug development and real-world health care adoption, ensuring that scientific innovations translate into meaningful patient outcomes.
AJ brings over 15 years of experience in clinical research, patient insights, and health outcomes assessment to help clients optimize trial implementation, accelerate evidence generation, and improve regulatory and payer confidence. His ability to integrate Implementation Science into clinical trial design and patient engagement strategies allows pharmaceutical companies to anticipate and address adoption challenges early, reducing delays in treatment uptake. He has introduced innovative data collection methodologies that enhance study design and improve the validity of real-world evidence, helping clients make informed, data-driven decisions that maximize the impact of their therapies.
“We’re thrilled to welcome AJ to our team,” said Chris Simmons, Senior Vice President for RTI Health Solutions. “His expertise in Implementation Science and real-world evidence generation will be invaluable in helping our clients navigate the complexities of treatment uptake and adherence.”
At RTI-HS, AJ will continue driving evidence-based strategies across key therapeutic areas, including oncology, hematology, immunology, rare diseases, and cell therapy. His work will support pharmaceutical companies in optimizing trial implementation, improving healthcare workflows, and integrating digital health solutions to enhance clinical trial outcomes.
Hear AJ's thoughts on Implementation Science in this video:
